about
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific T...
Read More
10.40
0.27
(2.67%)
830.3K
XNAS Volume
XNAS 10 Mar, 2026 5:30 PM (EDT)
Board Meeting
The latest board meeting for Immix Biopharma Inc took place on 10 Mar 2026, for the purpose of The Citizens Life Sciences Conference
See details
Not Eligible
Expensive Valuation
Technically Bullish
Immix Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..